Literature DB >> 1673073

Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.

J Sallés1, A Badia.   

Abstract

1. The factors underlying the different responsiveness of the prostatic and epididymal portions of rat vas deferens to alpha 1-adrenoceptor stimulation were investigated. 2. The alpha 1-adrenoceptors in membranes of both halves of rat vas deferens were labelled with [3H]-prazosin and the affinities of agonists and antagonists for these receptors were determined. In saturation studies, the Bmax and KD values for [3H]-prazosin in membranes of both portions were the same. 3. In competition studies, the inhibition curves for phentolamine were biphasic and consistent with the presence of both alpha 1a- and alpha 1b-adrenoceptor subtypes. The proportions of binding sites with high and low affinity for phentolamine in both halves of rat vas deferens were similar and in good agreement with the percentages of binding sites for WB-4101 and phentolamine previously reported in the whole rat vas deferens. 4. The phenylethylamines displaced [3H]-prazosin with a shallow inhibition curve. The data are compatible with the assumption of two affinity states for the binding sites. For the imidazoline compounds no such distinct affinity states could be demonstrated. 5. The affinity for, and the relative intrinsic efficacy on postsynaptic alpha 1-adrenoceptors of both portions of rat vas deferens were studied for noradrenaline, phenylephrine and methoxamine by irreversible inactivation of the alpha 1-adrenoceptors by phenoxybenzamine. The parameters for partial agonists were determined by comparing the responses to the partial agonist to those of a full agonist in the same tissue. Homogeneous estimates of the equilibrium dissociation constants (Ka) were obtained, indicating that these agonists bind to the receptors of both tissues in an identical manner. Further, estimation of the intrinsic efficacy of agonists relative to noradrenaline, indicated no differences between the two halves of rat vas deferens. 6. Ka values for agonist activation of the functional alpha 1-adrenoceptors were compared with K, values for agonist inhibition of specific [3H]-prazosin binding. The K. values were well correlated with the low affinity K, values for phenylethylamines in both portions of rat vas deferens, suggesting that the initial event in signal transduction by alpha 1,-adrenoceptors is the binding to the low affinity state of the receptor. 7. There was a non-linear relationship between response and receptor occupancy in both halves of rat vas deferens but the occupancy-response coupling was more efficient in the epididymal than in the prostatic portion. This fact may account for the differences observed in the functional responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673073      PMCID: PMC1918043          DOI: 10.1111/j.1476-5381.1991.tb12192.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Alpha 1-adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sites.

Authors:  G Hanft; G Gross; J J Beckeringh; C Korstanje
Journal:  J Pharm Pharmacol       Date:  1989-10       Impact factor: 3.765

2.  Effects of St-587 on the alpha-adrenoceptors in the bisected rat vas deferens.

Authors:  A Badia; J Sallés
Journal:  J Pharm Pharmacol       Date:  1989-09       Impact factor: 3.765

3.  Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle.

Authors:  C Han; P W Abel; K P Minneman
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

4.  On the measurement of the affinity of partial agonists for receptors.

Authors:  D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1969-11       Impact factor: 4.030

5.  Alpha 1-adrenoceptors of rat myocardium: comparison of agonist binding and positive inotropic response.

Authors:  G Gross; G Hanft; C U Rugevics
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

6.  Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.

Authors:  A L Morrow; I Creese
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

7.  Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.

Authors:  G Hanft; G Gross
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Modulation of agonist and antagonist interactions at kidney alpha 1-adrenoceptors by nucleotides and metal ions.

Authors:  P Ernsberger; D C U'Prichard
Journal:  Eur J Pharmacol       Date:  1987-01-13       Impact factor: 4.432

10.  Relationship between alpha-adrenoceptor occupancy and contractile response in rat vas deferens. Experimental and theoretical analysis.

Authors:  A Díaz-Toledo; M C Martí
Journal:  Eur J Pharmacol       Date:  1988-11-08       Impact factor: 4.432

View more
  7 in total

1.  Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens.

Authors:  Nnaemeka I B Amobi; John Guillebaud; A V Kaisary; Eileen Turner; I Christopher H Smith
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

2.  Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats.

Authors:  M Guitart; J Giraldo; E Goñalons; E Vila; A Badia
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.

Authors:  R Bültmann; A K Kurz; K Starke
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

4.  Study of the mechanism of the relaxant action of (+)-glaucine in rat vas deferens.

Authors:  F Orallo; A Fernández Alzueta; M I Loza; N Vivas; A Badía; M Campos; M A Honrubia; M I Cadavid
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.

Authors:  J Sallés; A Badia
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.

Authors:  T Ohmura; M Oshita; S Kigoshi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

7.  Physiological and pharmacological aspects of the vas deferens-an update.

Authors:  David S Koslov; Karl-Erik Andersson
Journal:  Front Pharmacol       Date:  2013-08-22       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.